发明名称 METHOD OF DETERMINING THE PROBABILITY OF A THERAPEUTIC RESPONSE IN CANCER CHEMOTHERAPY WITH CARDIAC GLYCOSIDE
摘要 A method of treatment employing cardiac glycoside is disclosed. A prognostic assay and kit and method of use thereof are provided. The kit and assay are used to determine the likelihood of a diseased cell or tissue having a therapeutic response to treatment with a cardiac glycoside in a disease having an etiology associated with excessive cell proliferation. The kit and assay are used to determine the ratio of isoforms of the α subunit of Na, K-ATPase obtained from the diseased cell or tissue. The kit can be used to predict the therapeutic responsiveness of cancer or tumor in a subject to treatment with a cardiac glycoside. The kit and assay can be incorporated in a method of treating a disease or disorder having an etiology associated with excessive cell proliferation with a composition comprising a cardiac glycoside.
申请公布号 EP2231165(B1) 申请公布日期 2013.05.15
申请号 EP20080850574 申请日期 2008.11.06
申请人 PHOENIX BIOTECHNOLOGY INC. 发明人 NEWMAN, ROBERT, A.;YANG, PEIYING;ADDINGTON, O., CRANDELL
分类号 G01N33/574;A61K31/58;A61K31/704;A61K36/24;G01N33/564 主分类号 G01N33/574
代理机构 代理人
主权项
地址